AIFM2 and toxic epidermal necrolysis: One limitation is the lack of an SJS/TEN animal model, it is essential and interesting to study SJS/TEN-related keratinocyte lipid metabolism dysregulation in vivo after treatment with miR-375-3p inhibitor and FSP1 or FTH1 antagonists.